Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 6, Pages 1492
Publisher
MDPI AG
Online
2020-06-09
DOI
10.3390/cancers12061492
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
- (2020) Jerri C. Caldeira et al. Viruses-Basel
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cystine–glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity
- (2019) Michael D. Arensman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Benzophenone-3 passes through the blood-brain barrier, increases the level of extracellular glutamate and induces apoptotic processes in the hippocampus and frontal cortex of rats
- (2019) Pomierny Bartosz et al. TOXICOLOGICAL SCIENCES
- In silico characterization of residues essential for substrate binding of human cystine transporter, xCT
- (2019) Monika Sharma et al. JOURNAL OF MOLECULAR MODELING
- Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
- (2018) Roberto Ruiu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
- (2018) Xiangming Ji et al. ONCOGENE
- Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells
- (2018) Gaetano Donofrio et al. OncoImmunology
- The global burden of women’s cancers: a grand challenge in global health
- (2017) Ophira Ginsburg et al. LANCET
- Cancer stem cells: The root of tumor recurrence and metastases
- (2017) Claudia Peitzsch et al. SEMINARS IN CANCER BIOLOGY
- The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility
- (2017) Chun-Shik Shin et al. Nature Communications
- Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells
- (2017) Emmanuel Dornier et al. Nature Communications
- Virus like particles as a platform for cancer vaccine development
- (2017) Hui Kian Ong et al. PeerJ
- A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo
- (2017) Elisabetta Bolli et al. OncoImmunology
- The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(--)
- (2016) K. Tsuchihashi et al. CANCER RESEARCH
- Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability
- (2016) Laura R. de la Ballina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway
- (2016) Sheng-Fan Wang et al. Oncotarget
- Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells
- (2016) Masanori Hasegawa et al. Oncotarget
- Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation
- (2016) Jianmin Wang et al. Oncotarget
- Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications
- (2016) Huai-Qiang Ju et al. Theranostics
- Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems
- (2015) Zeinab Shirbaghaee et al. BIOPOLYMERS
- Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
- (2015) Ming-zhe Ma et al. CANCER LETTERS
- Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
- (2015) S. Lanzardo et al. CANCER RESEARCH
- Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice
- (2015) Ikuko Miyazaki et al. JOURNAL OF NEUROCHEMISTRY
- PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNAPCA3
- (2015) Ahmad Salameh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
- (2015) Stephanie M. Robert et al. Science Translational Medicine
- Behavioral characterization of system xc- mutant mice
- (2014) Elizabeth A. McCullagh et al. BEHAVIOURAL BRAIN RESEARCH
- RETRACTED ARTICLE: Suppression of the xCT–CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin
- (2014) Feng Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Virus-Like Display of a Neo-Self Antigen Reverses B Cell Anergy in a B Cell Receptor Transgenic Mouse Model
- (2014) Bryce Chackerian et al. JOURNAL OF IMMUNOLOGY
- Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
- (2013) Luika A. Timmerman et al. CANCER CELL
- xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma
- (2013) M. Yoshikawa et al. CANCER RESEARCH
- The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells
- (2013) Laura Conti et al. FASEB JOURNAL
- Redox regulation in stem-like cancer cells by CD44 variant isoforms
- (2013) O Nagano et al. ONCOGENE
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- The evolving concept of cancer and metastasis stem cells
- (2012) Irène Baccelli et al. JOURNAL OF CELL BIOLOGY
- Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma
- (2012) HIROKI KINOSHITA et al. ONCOLOGY REPORTS
- Activated human CD4+ T cells express transporters for both cysteine and cystine
- (2012) Trine Bøegh Levring et al. Scientific Reports
- Peptide Epitope Identification by Affinity Selection on Bacteriophage MS2 Virus-Like Particles
- (2011) Bryce Chackerian et al. JOURNAL OF MOLECULAR BIOLOGY
- Differential Dependence on Cysteine from Transsulfuration versus Transport During T Cell Activation
- (2010) Sanjay K. Garg et al. ANTIOXIDANTS & REDOX SIGNALING
- Attenuation of PI3K/Akt-Mediated Tumorigenic Signals through PTEN Activation by DNA Vaccine-Induced Anti-ErbB2 Antibodies
- (2010) A. Porzia et al. JOURNAL OF IMMUNOLOGY
- The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
- (2008) M Lo et al. BRITISH JOURNAL OF CANCER
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway
- (2008) R-S Chen et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search